CYTOF Projected Dividend Yield
Altamira Therapeutics Ltd ( OTCBB : CYTOF )Altamira Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on developing therapeutics that address unmet medical needs. Co. has been focusing on the development of therapeutics for inner ear disorders: Keyzilen® (AM-101) in acute inner ear tinnitus, Sonsuvi® (AM-111) in acute inner ear hearing loss and AM-125 in acute peripheral vertigo. Co. has launched Bentrio™, a drug free medical device for protection against airborne allergens and viruses in selected European markets. Further, Co. has entered the field of RNA delivery. 21 YEAR PERFORMANCE RESULTS |
CYTOF Dividend History Detail CYTOF Dividend News CYTOF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |